FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia
2022 · Cell Death and Disease · 97 citations
https://doi.org/10.1038/s41419-022-05091-2
B
Bo Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
674
Citations
12
h-index
15
i10-index
Bo Li is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Autophagy in Disease and Therapy & Cancer-related Molecular Pathways & Esophageal Cancer Research and Treatment. The author has an h-index of 12, co-authored 23 publications.
ORCID: 0000-0002-1319-1454Papers by this author
worksMitophagy in carcinogenesis, drug resistance and anticancer therapeutics
2021 · Cancer Cell International · 87 citations
https://doi.org/10.1186/s12935-021-02065-w
Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer
2014 · Cell Death and Disease · 18 citations
https://doi.org/10.1038/cddis.2014.283
Parkin-mediated mitophagy protects against aluminum trichloride-induced hippocampal apoptosis in mice via the mtROS-NLRP3 pathway
2023 · Ecotoxicology and Environmental Safety · 13 citations
https://doi.org/10.1016/j.ecoenv.2023.115459
Research on Lung Cancer Classification Based on Multidimensional Hematological Indicators and Machine Learning Models
2026 · Journal of Evidence-Based Medicine · 0 citations
https://doi.org/10.1111/jebm.70119
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat